Gabriele Masi

Fondazione Stella Maris

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Annarita Milone

Fondazione Stella Maris

María Mucci

Istituti di Ricovero e Cura a Carattere Scientifico

Pietro Muratori

Fondazione Stella Maris

Stefano Berloffa

Fondazione Stella Maris

Stefania Millepiedi

University of Pisa

Chiara Pfanner

Fondazione Stella Maris

Simone Pisano

University of Naples Federico II

Gianluca Sesso

IMT School for Advanced Studies Lucca

Paola Brovedani

Fondazione Stella Maris

Alessandro Zuddas

University of Cagliari

Cooperative Institutions

Istituti di Ricovero e Cura a Carattere Scientifico

233

University of Pisa

181

Fondazione Stella Maris

150

University of Bari Aldo Moro

University of Padua

Sapienza University of Rome

RELX Group (United States)

University of Florence

University of Naples Federico II

Azienda Ospedaliera Universitaria Pisana

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Callous unemotional traits in children with disruptive behavior disorder: Predictors of developmental trajectories and adolescent outcomes

Psychiatry Research (2016)

Pietro Muratori John E. Lochman Azzurra Manfredi Annarita Milone Annalaura Nocentini

Conduct disorder

Longitudinal Study

Latent growth modeling

10.1016/j.psychres.2016.01.003

Cite

Citations (42)

Which dimension of parenting predicts the change of callous unemotional traits in children with disruptive behavior disorder?

Comprehensive Psychiatry (2016)

Pietro Muratori John E. Lochman Elisa Lai Annarita Milone Annalaura Nocentini

Conduct disorder

Parenting styles

Child psychopathology

10.1016/j.comppsych.2016.06.002

Cite

Citations (42)

Reactivity of Emotions in Adolescents - Caregivers' Tool (React): Development and Validation of a Novel Parent-Rated Measure for Assessing Emotional Dysregulation in Youth.

PubMed (2024)

Gianluca Sesso Fulvio Guccione L Conti Elena Valente Antonio Narzisi

Emotional Dysregulation (ED) is characterized by the inability to manage emotions effectively, leading to maladaptive behaviors, and often co-occurs with psychiatric conditions carrying significant long-term consequences. Early diagnosis of ED is thus essential for targeted interventions. To address this need, we developed and validated the "Reactivity of Emotions in Adolescents: Caregivers' Tool" (REACT), a novel parent-rated questionnaire designed to assess ED in adolescents.

Reactivity

Positive Youth Development

Emotional dysregulation

10.36131/cnfioritieditore20240404

Cite

Citations (0)

Meyer-Schwickherath syndrome; case report

S Chiellini Federica Genovesi-Ebert G. Cocciolo G Benini G Cavallacci

Source

Cite

Citations (0)

P.209 The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium)

European Neuropsychopharmacology (2020)

Carla Balia Sara Carucci Annarita Milone Roberta Romaniello Elena Valente

Biocompatible material

Bacterial Cellulose

Magnetism

Characterization

10.1016/j.euroneuro.2020.09.157

Cite

Citations (0)

O-7 Evidence of therapeutic effectiveness of third-line cetuximab rechallenge in appropriately selected patients: Findings from long-term follow-up of CRICKET and CAVE trials

Annals of Oncology (2022)

E. Martinelli Giovanni Maria Martini Davide Ciardiello Vincenzo Famiglietti Daniele Rossini

Panitumumab

Progression-free survival

10.1016/j.annonc.2022.04.448

Cite

Citations (2)

<p>Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment</p>

Neuropsychiatric Disease and Treatment (2019)

Gabriele Masi Pamela Fantozzi Arianna Villafranca Annalisa Tacchi Federica Ricci

Methylphenidate (MPH), the first-line medication in children with attention-deficit/hyperactivity disorder (ADHD), is associated with increased risk of sleep disorders. Melatonin has both hypnotic and chronobiotic properties that influence circadian rhythm sleep disorders. This study explores the effectiveness of melatonin in children with ADHD who developed sleep problems after starting MPH.This study, based on a clinical database, included 74 children (69 males, mean age 11.6±2.2 years) naturalistically treated with MPH (mean dosage 33.5±13.5 mg/d). The severity of sleep disorder (sleep onset delay) was recorded at baseline and after a follow-up of at least 4 weeks using a seven-point Likert scale according to the Clinical Global Impression Severity score. Effectiveness of melatonin on sleep (mean dosage 1.85±0.84 mg/d) after 4 weeks was assessed using a seven-point Likert scale according to the Clinical Global Impression Improvement (CGI-I) score, and patients who scored 1 (very much improved) or 2 (much improved) were considered responders.Clinical severity of sleep disorders was 3.41±0.70 at the baseline and 2.13±1.05 after the follow-up (P<0.001). According to the CGI-I score, 45 patients (60.8%) responded to the treatment with melatonin. Gender and age (children younger and older than 12 years) did not affect the response to melatonin on sleep. Patients with or without comorbidities did not differ according to sleep response. Specific comorbidities with disruptive behavior disorders (oppositional defiant disorder or conduct disorder), affective (mood and anxiety) disorders and learning disabilities did not affect the efficacy of melatonin on sleep. Treatment was well tolerated, and no side effects related to melatonin were reported.In children with ADHD with sleep problems after receiving MPH treatment, melatonin may be an effective and safe treatment, irrespective of gender, age and comorbidities.

Sleep

Attention deficits

Attention deficit disorder

10.2147/ndt.s193891

Cite

Citations (22)

Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children

European Archives of Psychiatry and Clinical Neuroscience (2022)

Sara Carucci Roberta Romaniello Giovanni Demuru Paolo Curatolo Clementina Grelloni

Placebo-controlled study

Depression

10.1007/s00406-022-01428-2

Cite

Citations (10)

Comorbidity of Conduct Disorder and Bipolar Disorder in Clinically Referred Children and Adolescents

Journal of Child and Adolescent Psychopharmacology (2008)

Gabriele Masi Annarita Milone Azzurra Manfredi Cinzia Pari Antonella Paziente

Objective: The co-occurrence of conduct disorder (CD) and bipolar disorder (BD) has been frequently reported in referred children and adolescents. We address the implications of this comorbidity in a naturalistic sample of youths with BD, CD, and CD+BD. Methods: The sample consisted of 307 patients (216 males and 91 females, age range 8–18 years, mean age 13.5 ± 2.6 years) referred during a 5-year period and followed-up for at least 6 months, 106 with CD without BD, 109 with BD without CD, and 92 with CD+BD, diagnosed with a structured clinical interview (K-SADS-PL). Results: Patients with CD alone were more predominantly males and with the lowest socio-economic status. Patients with CD without BD were the least severe at the baseline, while patients with BD alone presented the greatest improvement during the follow-up, and those with CD+BD had the poorest response. Patients with CD+BD presented higher rates of global aggression at the baseline, namely impulsive aggression, compared with CD alone, and the highest risk of substance abuse. Patients with BD alone presented higher rates of comorbid panic disorder and obsessive compulsive disorder, while patients with CD, with or without BD, had higher rates of ADHD. Conclusions: Bipolar-conduct disorder comorbidity may have meaningful implications in children and adolescents, in terms of presentation, course, and treatments.

Conduct disorder

Bipolar I disorder

10.1089/cap.2008.0051

Cite

Citations (30)

[Neuropsychology of deficient development].

PubMed (1991)

P Pfanner M Marcheschi Gabriele Masi

Source

Cite

Citations (0)